SCHEMBL742974

SCHEMBL742974

CN1CCc2cc(C(=O)O)sc2C1.[LiH]

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
DAO P14920 1/20 0.54
WDR91 A4D1P6 1/20 0.49
HDAC6 Q9UBN7 3/20 0.46
F10 P00742 1/20 0.46
KDM4E B2RXH2 3/20 0.46
MAPT P10636 2/20 0.46
ADORA1 P30542 1/20 0.46
RAD52 P43351 1/20 0.46
PARP1 P09874 3/20 0.42
PARP2 Q9UGN5 3/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PRMT5 O14744 1/20 0.40
WDR77 Q9BQA1 1/20 0.40
HPGD P15428 3/20 0.39
MEN1 O00255 1/20 0.39
GLA P06280 1/20 0.39
KMT2A Q03164 1/20 0.39
TBXAS1 P24557 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2761887 0.98 ALDH1A1 (0.56) ALDH1A1DAOWDR91HDAC6F10
SCHEMBL3309101 0.89 ALDH1A1 (0.64) ALDH1A1DAOWDR91HDAC6KDM4E
SCHEMBL3313449 0.86 ALDH1A1 (0.56) ALDH1A1DAOWDR91HDAC6F10
SCHEMBL10513283 0.86 WDR91 (0.50) ALDH1A1DAOWDR91HDAC6F10
SCHEMBL1174522 0.85 HDAC6 (0.53) ALDH1A1DAOWDR91HDAC6F10
Hydrochloric Acid SCHEMBL10514992 0.84 WDR91 (0.49) ALDH1A1DAOWDR91HDAC6F10
SCHEMBL31609056 0.83 ALDH1A1 (0.51) ALDH1A1DAOWDR91HDAC6KDM4E
Lithium Ion SCHEMBL742973 0.83 WDR91 (0.48) ALDH1A1DAOWDR91HDAC6F10
SCHEMBL30861168 0.79 ALDH1A1 (0.56) ALDH1A1DAOHDAC6KDM4EHPGD
SCHEMBL12922700 0.79 KDM4E (0.48) ALDH1A1WDR91HDAC6F10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2431370-B1 Monoacylated 1,2-diaminocycloalkanes DAIICHI SANKYO CO LTD (JP) 2013-06-19 EP disclosed
EP-1270557-B1 ETHYLENEDIAMINE DERIVATIVES DAIICHI SANKYO CO LTD (JP) 2012-07-25 EP disclosed
EP-2431370-A1 Monoacylated 1,2-diaminocycloalkanes DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2012-03-21 EP disclosed
US-7935824-B2 Ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2011-05-03 US disclosed
US-20090227789-A1 ETHYLENEDIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2009-09-10 US disclosed
US-20070129371-A1 Novel ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-06-07 US disclosed
US-7192968-B2 Ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-03-20 US disclosed
US-20060004009-A1 Ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-05 US disclosed
EP-1577302-A1 NOVEL ETHYLENEDIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-21 EP disclosed
US-20040122063-A1 Ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-06-24 US disclosed
EP-1270557-A1 ETHYLENEDIAMINE DERIVATIVES DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129371-A1 Novel ethylenediamine derivatives C1R, C9, C1S ALDH1A1 4310/4885DAO 2776/4885WDR91 2781/4885
US-20060004009-A1 Ethylenediamine derivatives F2, ECE1, MLLT1 ALDH1A1 2105/4885DAO 804/4885WDR91 3122/4885
US-20090227789-A1 ETHYLENEDIAMINE DERIVATIVES F2, ECE1, MLLT1 ALDH1A1 2105/4885DAO 804/4885WDR91 3122/4885
US-20040122063-A1 Ethylenediamine derivatives ECE1, F2, ECE2 ALDH1A1 2109/4885DAO 435/4885WDR91 3949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.